These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37933840)

  • 1. The forkhead DNA-binding domain binds specific G2-rich RNA sequences.
    Zutterling C; Todeschini AL; Fourmy D; Busso D; Veaute X; Ducongé F; Veitia RA
    Nucleic Acids Res; 2023 Dec; 51(22):12367-12380. PubMed ID: 37933840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FOXP2 forkhead domain binds to a variety of DNA sequences with different rates and affinities.
    Webb H; Steeb O; Blane A; Rotherham L; Aron S; Machanick P; Dirr H; Fanucchi S
    J Biochem; 2017 Jul; 162(1):45-54. PubMed ID: 28104810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel protein partners of the transcription factor FOXL2 provides insights into its physiopathological roles.
    L'Hôte D; Georges A; Todeschini AL; Kim JH; Benayoun BA; Bae J; Veitia RA
    Hum Mol Genet; 2012 Jul; 21(14):3264-74. PubMed ID: 22544055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatase is a direct target of FOXL2: C134W in granulosa cell tumors via a single highly conserved binding site in the ovarian specific promoter.
    Fleming NI; Knower KC; Lazarus KA; Fuller PJ; Simpson ER; Clyne CD
    PLoS One; 2010 Dec; 5(12):e14389. PubMed ID: 21188138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missense mutations in the forkhead domain of FOXL2 lead to subcellular mislocalization, protein aggregation and impaired transactivation.
    Beysen D; Moumné L; Veitia R; Peters H; Leroy BP; De Paepe A; De Baere E
    Hum Mol Genet; 2008 Jul; 17(13):2030-8. PubMed ID: 18372316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors.
    Llano E; Todeschini AL; Felipe-Medina N; Corte-Torres MD; Condezo YB; Sanchez-Martin M; López-Tamargo S; Astudillo A; Puente XS; Pendas AM; Veitia RA
    Cancer Res; 2023 Jan; 83(2):239-250. PubMed ID: 36409821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXO4 Transactivation Domain Interaction with Forkhead DNA Binding Domain and Effect on Selective DNA Recognition for Transcription Initiation.
    Kim J; Ahn D; Park CJ
    J Mol Biol; 2021 Feb; 433(4):166808. PubMed ID: 33450250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary.
    Jamieson S; Butzow R; Andersson N; Alexiadis M; Unkila-Kallio L; Heikinheimo M; Fuller PJ; Anttonen M
    Mod Pathol; 2010 Nov; 23(11):1477-85. PubMed ID: 20693978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXL2 and FOXA1 cooperatively assemble on the TP53 promoter in alternative dimer configurations.
    Choi Y; Luo Y; Lee S; Jin H; Yoon HJ; Hahn Y; Bae J; Lee HH
    Nucleic Acids Res; 2022 Aug; 50(15):8929-8946. PubMed ID: 35920317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential but differential role of FOXL2wt and FOXL2C134W in GDF-9 stimulation of follistatin transcription in co-operation with Smad3 in the human granulosa cell line COV434.
    Nonis D; McTavish KJ; Shimasaki S
    Mol Cell Endocrinol; 2013 Jun; 372(1-2):42-8. PubMed ID: 23523567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forkhead l2 is expressed in the ovary and represses the promoter activity of the steroidogenic acute regulatory gene.
    Pisarska MD; Bae J; Klein C; Hsueh AJ
    Endocrinology; 2004 Jul; 145(7):3424-33. PubMed ID: 15059956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Pathognomonic FOXL2 C134W Mutation Alters DNA-Binding Specificity.
    Carles A; Trigo-Gonzalez G; Cao Q; Cheng SG; Moksa M; Bilenky M; Huntsman DG; Morin GB; Hirst M
    Cancer Res; 2020 Sep; 80(17):3480-3491. PubMed ID: 32641414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Key Evolutionary Mutation Enhances DNA Binding of the FOXP2 Forkhead Domain.
    Morris G; Fanucchi S
    Biochemistry; 2016 Apr; 55(13):1959-67. PubMed ID: 26950495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMADs and FOXL2 synergistically regulate murine FSHbeta transcription via a conserved proximal promoter element.
    Tran S; Lamba P; Wang Y; Bernard DJ
    Mol Endocrinol; 2011 Jul; 25(7):1170-83. PubMed ID: 21622537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of FOXL2 C134W Mutation Status by a Novel BaseScope In Situ Hybridization Assay is Highly Sensitive and Specific for Adult Granulosa Cell Tumors.
    Hammer PM; Wang A; Beard C; Zdravkovic S; Tenney T; Liang B; Das I; Bremer R; Wang LC; McCluggage WG; Stewart CJR; Howitt BE
    Mod Pathol; 2023 Nov; 36(11):100318. PubMed ID: 37634867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foxl2 up-regulates aromatase gene transcription in a female-specific manner by binding to the promoter as well as interacting with ad4 binding protein/steroidogenic factor 1.
    Wang DS; Kobayashi T; Zhou LY; Paul-Prasanth B; Ijiri S; Sakai F; Okubo K; Morohashi K; Nagahama Y
    Mol Endocrinol; 2007 Mar; 21(3):712-25. PubMed ID: 17192407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXL2, GATA4, and SMAD3 co-operatively modulate gene expression, cell viability and apoptosis in ovarian granulosa cell tumor cells.
    Anttonen M; Pihlajoki M; Andersson N; Georges A; L'hôte D; Vattulainen S; Färkkilä A; Unkila-Kallio L; Veitia RA; Heikinheimo M
    PLoS One; 2014; 9(1):e85545. PubMed ID: 24416423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant FOXL2
    Weis-Banke SE; Lerdrup M; Kleine-Kohlbrecher D; Mohammad F; Sidoli S; Jensen ON; Yanase T; Nakamura T; Iwase A; Stylianou A; Abu-Rustum NR; Aghajanian C; Soslow R; Da Cruz Paula A; Koche RP; Weigelt B; Christensen J; Helin K; Cloos PAC
    Cancer Res; 2020 Sep; 80(17):3466-3479. PubMed ID: 32641411
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Mubeen A; Parra-Herran C
    J Clin Pathol; 2023 Dec; 76(12):798-801. PubMed ID: 37798106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-binding properties of the MADS-domain transcription factor SEPALLATA3 and mutant variants characterized by SELEX-seq.
    Käppel S; Eggeling R; Rümpler F; Groth M; Melzer R; Theißen G
    Plant Mol Biol; 2021 Mar; 105(4-5):543-557. PubMed ID: 33486697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.